MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 64 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | – | 1,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 2,615,458 | $9,415,649 | 3.42% |
| MANGROVE PARTNERS IM, LLC | 8,752,893 | $31,510,415 | 2.42% |
| ACUTA CAPITAL PARTNERS, LLC | 677,000 | $2,437,200 | 2.05% |
| Rubric Capital Management LP | 15,307,347 | $55,106,449 | 1.44% |
| 683 Capital Management, LLC | 5,000,000 | $18,000,000 | 1.36% |
| Rock Springs Capital Management LP | 9,283,492 | $33,420,571 | 1.01% |
| Blue Owl Capital Holdings LP | 897,809 | $3,232,112 | 0.90% |
| Frazier Life Sciences Management, L.P. | 4,401,371 | $15,844,936 | 0.74% |
| Knoll Capital Management, LLC | 260,470 | $937,692 | 0.63% |
| Integral Health Asset Management, LLC | 1,775,000 | $6,390,000 | 0.61% |